BCN512 is an orally active inhibitor of the Wnt/beta-catenin signaling pathway that promotes the degradation of beta-catenin by activating GSK-3beta, thereby downregulating associated transcriptional activity. BCN512 inhibits the proliferation of colorectal cancer cells and induces differentiation, making it suitable for use in cancer therapy research.
Molekulargewicht:
347.39
Reinheit:
99.87%
CAS Nummer:
[346691-54-1]
Formel:
C16H17N3O4S
Target-Kategorie:
Wnt/beta-catenin
T212831
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten